High plasma C‐reactive protein (CRP) is related to low paraoxonase‐I (PON‐I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Clinical Endocrinology

• Publication date

  2009-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1365-2265.2008.03306.xPMID 18505467
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Relationship of adiponectin to serum paraoxonase 1.

  2008cited by this paper
• Lower plasma adiponectin is a marker of increased intima-media thickness associated with type 2 diabetes mellitus and with male gender.

  2007cited by this paper
• Higher plasma leptin largely explains increased C‐reactive protein levels in women

  2007cited by this paper
• C-reactive protein: a marker or a player?

  2007cited by this paper
• Adiponectin levels measured in dried blood spot samples from neonates born small and appropriate for gestational age.

  2007cited by this paper
• Genetic Variation, C-Reactive Protein Levels, and Incidence of Diabetes

  2007cited by this paper
• Adiponectin accelerates reverse cholesterol transport by increasing high density lipoprotein assembly in the liver.

  2007cited by this paper
• Genetic and environmental determinants of the PON‐1 phenotype

  2007cited by this paper
• Relationship of endogenous hyperleptinemia to serum paraoxonase 1, cholesteryl ester transfer protein, and lecithin cholesterol acyltransferase in obese individuals.

  2007cited by this paper
• Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis

  2006cited by this paper
• The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease.

  2006cited by this paper
• Defective Metabolism of Oxidized Phospholipid by HDL From People With Type 2 Diabetes

  2006cited by this paper
• Leptin and atherosclerosis.

  2006cited by this paper
• High C-reactive protein and low paraoxonase1 in diabetes as risk factors for coronary heart disease.

  2006cited by this paper
• Lower serum paraoxonase-1 activity in type 2 diabetic patients correlates with nitrated apolipoprotein A-I levels.

  2006cited by this paper
• C-reactive protein is a strong independent predictor of death in type 2 diabetes: association with multiple facets of the metabolic syndrome.

  2006cited by this paper
• Adiponectin Is an Important Determinant of ApoA-I Catabolism

  2006cited by this paper
• Correlation between the activities of lipoprotein lipase and paraoxonase in type 2 diabetes mellitus.

  2005cited by this paper
• Multiplexed analysis of biomarkers related to obesity and the metabolic syndrome in human plasma, using the Luminex-100 system.

  2005cited by this paper
• Indications that paraoxonase-1 contributes to plasma high density lipoprotein levels in familial hypercholesterolemia Published, JLR Papers in Press, December 1, 2004. DOI 10.1194/jlr.M400052-JLR200

  2005cited by this paper
• The endocrine function of adipose tissue: an update

  2005cited by this paper
• Post-heparin plasma lipoprotein lipase, but not hepatic lipase activity, is related to plasma adiponectin in type 2 diabetic patients and healthy subjects.

  2005cited by this paper
• Relation of plasma leptin to C-reactive protein in older adults (from the Invecchiare nel Chianti study).

  2005cited by this paper
• Adiponectin and C-reactive protein in obesity, type 2 diabetes, and monodrug therapy.

  2004cited by this paper
• Paraoxonase 1 activity, concentration and genotype in cardiovascular disease

  2004cited by this paper
• Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes.

  2004cited by this paper
• Paraoxonase-1 inhibits oxidised LDL-induced MCP-1 production by endothelial cells.

  2004cited by this paper
• Diabesity: An Inflammatory Metabolic Condition

  2003cited by this paper
• Reciprocal Association of C-Reactive Protein With Adiponectin in Blood Stream and Adipose Tissue

  2003cited by this paper
• Relations of plasma high-sensitivity C-reactive protein to traditional cardiovascular risk factors.

  2003cited by this paper
• Leptin decreases plasma paraoxonase 1 (PON1) activity and induces oxidative stress: the possible novel mechanism for proatherogenic effect of chronic hyperleptinemia.

  2003cited by this paper
• HDL and arteriosclerosis: beyond reverse cholesterol transport.

  2002cited by this paper
• Paraoxonase Status in Coronary Heart Disease: Are Activity and Concentration More Important Than Genotype?

  2001cited by this paper
• Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses

  2000cited by this paper
• Promoter polymorphisms of human paraoxonase PON1 gene and serum paraoxonase activities and concentrations.

  2000cited by this paper
• Serum arylesterase/diazoxonase activity and genetic polymorphisms in patients with type 2 diabetes.

  2000cited by this paper
• Glycation impairs high-density lipoprotein function

  2000cited by this paper
• Atherosclerosis--an inflammatory disease.

  1999cited by this paper
• Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus.

  1998cited by this paper
• Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response.

  1998cited by this paper
• Paraoxonase genotypes, lipoprotein lipase activity, and HDL.

  1996cited by this paper
• Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein.

  1995cited by this paper
• Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man

  1985cited by this paper

• Dietary total antioxidant capacity, cardiovascular risk, and anthropometric obesity indices in hemodialysis patients: A case-control study

  2024cites this paper
• Effect of Exercise Repetitions on Arylesterase Activity of PON1 in Plasma of Average-Trained Men—The Dissociation between Activity and Concentration

  2023cites this paper
• A baseline study on the impact of nanoplastics on the portals of entry of xenobiotics in fish.

  2021cites this paper
• Association between inflammatory markers and serum paraoxonase and arylesterase activities in the general population: a cross-sectional study

  2021cites this paper
• Acute phase proteins and total antioxidant capacity in free-roaming cats infected by pathogenic leptospires

  2020influential citation
• Inhibition of Human Serum Paraoxonase-I with Antimycotic Drugs: In Vitro and In Silico Studies

  2019cites this paper
• Effects of Securigera securidaca (L.) Degen & Dorfl seed extract combined with glibenclamide on paraoxonase1 activity, lipid profile and peroxidation, and cardiovascular risk indices in diabetic rats

  2019cites this paper
• Serum paraoxonase‐1 activity is inversely related to free thyroxine in euthyroid subjects: The PREVEND Cohort Study

  2018cites this paper
• Relation of Paraoxonase 1 Activity with Biochemical Variables, Brachial Artery Intima-Media Thickness in Patients with Diabetes with or without Obesity

  2018cites this paper
• Serum paraoxonase-1 activity is associated with light to moderate alcohol consumption: the PREVEND cohort study.

  2018cites this paper
• Serum paraoxonase 1 activity is paradoxically maintained in nonalcoholic fatty liver disease despite low HDL cholesterol[S]

  2018influential citation
• Serum Amyloid A, Paraoxonase-1 Activity, and Apolipoprotein Concentrations as Biomarkers of Subclinical Atherosclerosis Risk in Adrenal Incidentaloma Patients.

  2018cites this paper
• European versus Asian differences for the associations between paraoxonase‐1 genetic polymorphisms and susceptibility to type 2 diabetes mellitus

  2018cites this paper
• Assessment of the inhibitory effects and molecular docking of some sulfonamides on human serum paraoxonase 1

  2017cites this paper
• Incident type 2 diabetes is associated with HDL, but not with its anti-oxidant constituent - paraoxonase-1: The prospective cohort PREVEND study.

  2017cites this paper
• The anti-inflammatory function of HDL is impaired in type 2 diabetes: role of hyperglycemia, paraoxonase-1 and low grade inflammation

  2017cites this paper
• Paraoxonase-1 activity is positively related to phospholipid transfer protein activity in type 2 diabetes mellitus: Role of large HDL particles.

  2016cites this paper
• Paraoxonase-1 and adipokines: Potential links between obesity and atherosclerosis.

  2016cites this paper
• INFLUENCE OF OXIDATIVE STRESS AND INFLAMMATION ON THE DEVELOPMENT OF ISCHEMIC HEART DISEASE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

  2016cites this paper
• Lipids and apolipoproteins in cardiovascular disease

  2016cites this paper
• Serum paraoxonase-1 activity and risk of incident cardiovascular disease: The PREVEND study and meta-analysis of prospective population studies.

  2016cites this paper
• Vitamin E Improves Serum Paraoxonase-1 Activity and Some Metabolic Factors in Patients with Type 2 Diabetes: No Effects on Nitrite/Nitrate Levels

  2016cites this paper
• Effects of smoking cessation on serum leptin and adiponectin levels

  2015cites this paper
• Paraoxonase 1 activity and level of antibodies directed against oxidized low density lipoproteins in a group of an elderly population in Poland - PolSenior study.

  2015cites this paper
• Effect of Red Wine Consumption on Serum Oxidation and Adiponectin Levels in Overweight and Healthy Individuals

  2014cites this paper
• Serum paraoxonase-1 activity is more closely related to HDL particle concentration and large HDL particles than to HDL cholesterol in Type 2 diabetic and non-diabetic subjects.

  2014cites this paper
• Paraoxonases function as unique protectors against cardiovascular diseases and diabetes: Updated experimental and clinical data

  2014cites this paper
• The positive relationship of serum paraoxonase-1 activity with apolipoprotein E is abrogated in metabolic syndrome.

  2013cites this paper
• Paraoxonase (PON)-1 activity in overweight and obese children and adolescents: association with obesity-related inflammation and oxidative stress.

  2013cites this paper
• Paraoxonase-1 Activity in Overweight and Obese Children and Adolescents: Association with Obesity- Related Inflammation and Oxidative Stress Aktywność paraoksonazy-1 u dzieci i nastolatków z otyłością i nadwagą: związek ze stanem zapalnym i stresem oksydacyjnym

  2013cites this paper
• Resistin in gingival crevicular fluid and induction of resistin release by Porphyromonas gingivalis lipopolysaccharide in human neutrophils.

  2012cites this paper
• The Human Paraoxonase Gene Cluster As a Target in the Treatment of Atherosclerosis

  2012cites this paper
• Lesões oxidativas e atividade antioxidante em equinos submetidos a exercícios em esteira e suplementados com vitamina E (dl-alfa-tocoferol)

  2012cites this paper
• Effects of weight loss in obese cats on biochemical analytes related to inflammation and glucose homeostasis.

  2012cites this paper
• The plasma leptin/adiponectin ratio predicts first cardiovascular event in men: a prospective nested case-control study.

  2012cites this paper
• Lower serum paraoxonase-1 activity is related to linoleic and docosahexanoic fatty acids in type 2 diabetic patients.

  2012cites this paper
• Primary and secondary prevention of cardiovascular disease in diabetes with aspirin

  2012cites this paper
• Increased LCAT activity and hyperglycaemia decrease the antioxidative functionality of HDL

  2012cites this paper
• Validation of spectrophotometric assays for serum paraoxonase type-1 measurement in dogs.

  2012cites this paper
• Impact of Vitamin E Supplementation on Blood Pressure and Hs-CRP in Type 2 Diabetic Patients | doi: 10.5681/hpp.2012.009.

  2012cites this paper
• Biomarkers of oxidative stress, antioxidant defence and inflammation are altered in the senescence-accelerated mouse prone 8

  2012cites this paper
• Favorable Effect of Short-Term Lifestyle Intervention on Human Paraoxonase-1 Activity and Adipokine Levels in Childhood Obesity

  2011cites this paper
• Cholesteryl ester transfer protein inhibition in cardiovascular risk management: ongoing trials will end the confusion.

  2011cites this paper
• Apolipoprotein B/A‐I and total cholesterol/high‐density lipoprotein cholesterol ratios both predict cardiovascular events in the general population independently of nonlipid risk factors, albuminuria and C‐reactive protein

  2011cites this paper
• Carotid intima media thickness is associated with plasma lipoprotein‐associated phospholipase A2 mass in nondiabetic subjects but not in patients with type 2 diabetes

  2011cites this paper
• High-sensitivity C-reactive protein: a novel cardiovascular risk predictor in type 2 diabetics with normal lipid profile.

  2011cites this paper
• Do patients with aggressive periodontitis have evidence of diabetes? A pilot study.

  2011cites this paper
• The gingiva contains leptin and leptin receptor in health and disease

  2011cites this paper
• Lower serum paraoxonase-1 activity is related to higher serum amyloid a levels in metabolic syndrome.

  2011cites this paper
• IDENTIFICAZIONE DI BIOMARCATORI PER LA DIAGNOSI PRECOCE DEL TUMORE POLMONARE

  2010cites this paper
• The role of adiponectin on body composition, adipocyte differentiation, preadipocyte proliferation and its modulation of inflammation with high fat diets

  2010cites this paper
• Beneficial effects of reconstituted HDL on ex vivo and in vitro platelet reactivity

  2010cites this paper
• Adiponectin suppresses inflammatory responses at the early phase of atherosclerosis in hyperglycemic rats.

  2010cites this paper
• Carotid artery intima media thickness associates with skin autofluoresence in non‐diabetic subjects without clinically manifest cardiovascular disease

  2010cites this paper
• Plasma lecithin: cholesterol acyltransferase activity modifies the inverse relationship of C-reactive protein with HDL cholesterol in nondiabetic men.

  2010cites this paper
• Plasma apolipoprotein M is reduced in metabolic syndrome but does not predict intima media thickness.

  2009cites this paper
• Molecular characterization and expression analysis of the porcine paraoxonase 3 (PON3) gene.

  2009cites this paper
• Lipid transfer proteins : consequences for cellular cholesterol efflux and cardiovascular risk in diabetes mellitus

  2009cites this paper
• Identification de gènes impliqués dans le développement du tissu adipeux et caractérisation de PON3 et de son impact sur divers paramètres de production chez le porc

  2009cites this paper
• Serum paraoxonase‐I activity is unaffected by short‐term administration of simvastatin, bezafibrate, and their combination in type 2 diabetes mellitus

  2009cites this paper
• be-Validation of spectrophotometric assays for serum paraoxonase type-1 measurement in dogs

  year unknowncites this paper